Related references
Note: Only part of the references are listed.Is selective 5-HT1F receptor agonism an entity apart from that of the triptans in antimigraine therapy?
Eloisa Rubio-Beltran et al.
PHARMACOLOGY & THERAPEUTICS (2018)
Sex and gender differences in the treatment of Alzheimer's disease: A systematic review of randomized controlled trials
Marco Canevelli et al.
PHARMACOLOGICAL RESEARCH (2017)
Sex differences in outcomes of disease-modifying treatments for multiple sclerosis: A systematic review
Rui Li et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2017)
Perimenopause and Menopause Are Associated With High Frequency Headache in Women With Migraine: Results of the American Migraine Prevalence and Prevention Study
Vincent T. Martin et al.
HEADACHE (2016)
Sex Differences in Clinical Features of Early, Treated Parkinson's Disease
Erika F. Augustine et al.
PLOS ONE (2015)
Sex Differences in the Pharmacokinetics of Levodopa in Elderly Patients With Parkinson Disease
Tomoaki Kumagai et al.
CLINICAL NEUROPHARMACOLOGY (2014)
Comparing the Efficacy of Eletriptan for Migraine in Women During Menstrual and Non-Menstrual Time Periods: A Pooled Analysis of Randomized Controlled Trials
Rahul Bhambri et al.
HEADACHE (2014)
Gender and triptan efficacy: a pooled analysis of three double-blind, randomized, crossover, multicenter, Italian studies comparing frovatriptan vs. other triptans
Flavia Franconi et al.
NEUROLOGICAL SCIENCES (2014)
Efficacy of frovatriptan versus other triptans in the acute treatment of menstrual migraine: pooled analysis of three double-blind, randomized, crossover, multicenter studies
Gianni Allais et al.
NEUROLOGICAL SCIENCES (2012)
Ratio of means for analyzing continuous outcomes in meta-analysis performed as well as mean difference methods
Jan O. Friedrich et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2011)
Quantifying the return of headache in triptan-treated migraineurs: An observational study
Fred Sheftell et al.
CEPHALALGIA (2010)
Menstrual and nonmenstrual migraines differ in women with menstrually-related migraine
Brenda Pinkerman et al.
CEPHALALGIA (2010)
Sex Differences in Pharmacokinetics and Pharmacodynamics
Offie P. Soldin et al.
CLINICAL PHARMACOKINETICS (2009)
Impact of Recent Prior Opioid Use on Rizatriptan Efficacy. A Post Hoc Pooled Analysis
Tony W. Ho et al.
HEADACHE (2009)
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
David Moher et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Pathways to the best fit of triptans for migraine patients
M. G. Buzzi
CEPHALALGIA (2008)
Predictors of migraine headache recurrence: A pooled analysis from the eletriptan database
David W. Dodick et al.
HEADACHE (2008)
Gender differences in pharmacological response
Gail D. Anderson
EPILEPSY IN WOMEN: THE SCIENTIFIC BASIS FOR CLINICAL MANAGEMENT (2008)
Pharmacokinetic and pharmacodynamic variability as possible causes for different drug responses in migraine. A comment
P. Tfelt-Hansen et al.
CEPHALALGIA (2007)
Time to pain freedom and onset of pain relief with rizatriptan 10 mg and prescription usual-care oral medications in the acute treatment of migraine headaches: A multicenter, prospective, open-label, two-attack, crossover study
Christopher F. Bell et al.
CLINICAL THERAPEUTICS (2006)
Sex-based differences in response to recombinant tissue plasminogen activator in acute ischemic stroke - A pooled analysis of randomized clinical trials
DM Kent et al.
STROKE (2005)
Triptans and CNS side-effects: pharmacokinetic and metabolic mechanisms
DW Dodick et al.
CEPHALALGIA (2004)
Migraine prevalence during menopausal transition
SJ Wang et al.
HEADACHE (2003)
Gender differences in adverse drug reactions: analysis of spontaneous reports to a Regional Pharmacovigilance Centre in France
JL Montastruc et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2002)
Triptans (serotonin, 5-HT1B/1D agonists) in migraine:: detailed results and methods of a meta-analysis of 53 trials
MD Ferrari et al.
CEPHALALGIA (2002)
The pharmacokinetics of the antimigraine compound zolmitriptan in Japanese and Caucasian subjects
RA Yates et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2002)
Clinical pharmacokinetics of frovatriptan
P Buchan et al.
HEADACHE (2002)
Tolerability and efficacy of almotriptan in the long-term treatment of migraine
J Pascual et al.
EUROPEAN NEUROLOGY (2001)
Share Paper
